Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04987619
Other study ID # BEETROOT JUICE
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 5, 2021
Est. completion date August 29, 2021

Study information

Verified date July 2021
Source Maimónides Biomedical Research Institute of Córdoba
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to evaluate the effects of beetroot juice supplements on lower-limb strength and muscular endurance in physically active women, due to the presence of NO3- in beetroot juice.


Description:

Beetroot juice (BJR) is used as an ergogenic aid, but no study has analyzed its' effects on explosive force production in physically active women. It has been proposed that females could blunt reduction of NO2- to NO based on a higher oxidative skeletal muscle phenotype than males. However, it has been observed a higher increase on plasma NO2- levels after supplementation compared to and a greater enhancement on muscle contractile function. Based on the absence of any study that has analyzed the effect of NO3- supplements on jump ability and power production on weightlifting on female population; the purpose of this study will be to investigate the possible ergogenic effect of BJR on physically active women on explosive force production and muscular endurance in a lower-limb body weightlifting protocol, due to the presence of NO3- in BJR and its effects.


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date August 29, 2021
Est. primary completion date August 29, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - Physically active females with 18-30 years of age - More than 6 months on RT training programs - Be familiarized with back squat, leg press and leg extension exercises - Not consuming any type of nutritional supplement or anabolic substances in the previous three months or during the study - Not suffering from a musculoskeletal injury that could interfere with the exercise protocol during the investigation Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Beetroot juice
Subjects will drink juice 120 minutes before each visit
Other:
Capri-Sun
70 mL of blackcurrant beverage, which is depleted of NO3- will be taken 120 min before each visit.

Locations

Country Name City State
Brazil Studies Research Group in Neuromuscular Responses (GEPREN), University of Lavras Lavras
Spain Department of Food Science and Technology, Rabanales University Campus, University of Cordoba Córdoba
Spain Department of Nursing Pharmacology and Physiotherapy, Faculty of Medicine and Nursing, University of Córdoba Córdoba
Spain Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba Córdoba
Spain Metabolism and Investigation Unit, Maimonides Biomedical Research Institute of Cordoba (IMIBIC),Reina Sofia University Hospital, University of Cordoba Córdoba
Spain Departamento de Motricidad Humana y Rendimiento Deportivo, Universidad de Sevilla Sevilla

Sponsors (1)

Lead Sponsor Collaborator
Maimónides Biomedical Research Institute of Córdoba

Countries where clinical trial is conducted

Brazil,  Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of height reached in jump Evaluated through CMJ (Counter movement jump) test with a recovery period of 45 seconds between jumps. Week 1, 2 and 3.
Secondary Movement velocity Evaluated at 50% and 75% repetition maximum (RM) Visit 1 (week 1), 2 (week 2) and 3 (week 3).
Secondary Power on back squat Evaluated at 50% and 75% repetition maximum (RM) Visit 1 (week 1), 2 (week 2) and 3 (week 3).
Secondary Muscular endurance test The test consists of three exercises: back squat, leg press and leg extension. Three series will be performed until concentric failure at 75% RM, three minutes of rest between each series. Visit 1 (week 1), 2 (week 2) and 3 (week 3).
Secondary Rating of perceived exertion (RPE). Immediately at the end of the muscular endurance test, participants will be instructed to report their RPE using a scale 1-10 (worse to better outcome). Visit 1 (week 1), 2 (week 2) and 3 (week 3).
See also
  Status Clinical Trial Phase
Completed NCT04734743 - Muscle Strength, Functional Capacity, Respiratory Function and Quality Of Life In Cystic Fibrosis Patients N/A
Completed NCT05189652 - Effect of Remote Myofascial Release on Lower Limb N/A